Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

AFTER suffering a fever and losing her voice, mum-of-four Kirsty Lawson thought she was the victim of a nasty winter virus.

Poor physical performance in patients with non-Hodgkin lymphoma receiving CAR T-cell therapy was linked to worse survival and ...

A Scots schoolboy has 'rang the bell' to celebrate beating cancer after his symptoms were originally mistaken for norovirus.

The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...

CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...

Protect your pet from potential glyphosate risks. Learn exposure sources, safety tips & protective strategies in WellBeing ...

Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...

Some New York doctors are working on new ways to treat advanced cancers. Chimeric Antigen Receptor, or CAR, T-cell therapy treats certain blood cancers by genetically modifying a person’s T-cells to ...

A BRAVE Greenock youngster marked International Childhood Cancer Day by ringing the bell to signal he is all clear of the ...